MedTrace Logo

Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus

NCT02219100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 613

Last updated 2014-08-19

No results posted yet for this study

Summary

This study examined the acceptability and feasibility of using a simplified regimen of medical abortion in Armenia and Azerbaijan. It was hypothesized that home use of mifepristone and misoprostol, and buccal administration of misoprostol, would be both acceptable to women and efficacious.

Conditions

  • Abortion, First Trimester

Interventions

DRUG

Home administration of 200 mg mifepristone

Home administration of 200 mg mifepristone

Sponsors & Collaborators

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Beverly Winikoff, MD, MPH · Gynuity Health Projects

  • Rena Bagirova, MD · Antenatal Clinic

  • Mehriban Huseynova, MD · Gynecology Department of the Central Regional Hospital

  • Aram Avalyan, MD · Vanadzor Hospital #1

  • Alla Minasyan, MD · Gyumri Maternity Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • Armenia
  • Azerbaijan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02219100 on ClinicalTrials.gov